0x799

• 0x799 14 Jan 2024 22:03 UTC

  1 point

  0 ∶ 0

  in reply to: David T’s comment on: Tu­ber­cu­lo­sis: Pre­pare to fund new MDR-TB reg­i­mens?

  Ah—where are you seeing that? The endTB page mentions under “What’s next?” the phase III endTB-Q trial, but that’s for pre-XDR TB, with “results [...] expected in late 2024″.

• 0x799 14 Jan 2024 21:59 UTC

  1 point

  0 ∶ 0

  in reply to: Joel Tan’s comment on: Tu­ber­cu­lo­sis: Pre­pare to fund new MDR-TB reg­i­mens?

  Thanks! I don’t use LinkedIn—is it within the bounds of propriety to tag his EA Forum account here?

• 0x799 2 Jan 2024 8:10 UTC

  2 points

  0 ∶ 0

  on: [Cause Ex­plo­ra­tion Prizes] Tuberculosis

  “directly observed therapy, short-chouse (DOTS) coverage” looks like a somewhat confusing typo of “directly observed therapy, short-course (DOTS) coverage”, unless I’m about to learn a new medical term.